Targeted therapies show initial effectiveness in subset of papillary thyroid cancer

Via Top Health News -- ScienceDaily

Two immunotherapy drugs currently approved by the US Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer, according to new research.

View original post here:

%d bloggers like this: